. [=] . ‘’ . . . . . , . . , . . . ‘’ . = . . . . = . (CDC) , . 1 . . 10 . . = , , . , . . , . = . . 2 15g . , , . = . . . . . . . . youngchaeyi@kormedi.com ' ' (https://kormedi.co… [+5 chars]
. . . - - - - - - - - - . , , . , , . . . () . . . . , , HPV , , , , . /. . +URL .
. [=] . , , . . . ? … , ? (Pierre Dukan) . . , , . . . . . - 40% 40.4% . 15.4%, 2.0% . . . … ? . . . . . . . . . BMI… (BMI) . BMI . . 47% 3 ‘8 ’ BMI . BMI 23~24.9 , 25 . … ? … [+63 chars]
. [=] . . 41.9% 6~8 . . . [=] . . , . , . . 10 . . [=] , . , , . 119 , . , , , . , . . . . [=] , , … [+134 chars]
Becky Maynard 10 . , . 44 . 48 Maynard . . . . . . 3 . PTSD “ ” . .[They] . . . [HRT] GP “ 2 ” . Maynard . . HRT GP . . Perimenopause . . 40 , . . . 3 NHS ‘’ , ( ) ‘ ’ . , . , , . . 40 … [+638 chars]
2018 23 14 , 23 . 97% 23 . . . " "1. . (Leptin) . . . . . 2. . , . . . . . 3. 2000 . . . . " ". , . . " "1. . . (Universität Zürich) . , . 2. . 10 . 4 , 6 . 3. . . . . , , , , , . 4. , . .
. [=] . . , . . 6~10 137 . , , . , , . . . , , . . 5~7 85 64 4 . , , , . . , . . 5 10 . 5 , . , , . . Children prefer natural food, too together@kormedi.com ' ' (https://kormed… [+9 chars]
' ( )' . pTau-181 APOE4 . , (CSF) pTau-181 . , (FDA) ' (Elecsys Amyloid Plasma Panel)' (breakthrough device designation) . Thomas Schinecker CEO " " " " . PET …" " , . , 2.8 " " . … [+155 chars]
[ ] ABL '()ABL' 27 . · , , ·, · . 50 1 20~30 . · 1 3~5 . ‘ ’ . 40 1000, 90 , 20 6700 5300. 30 75 500 3000. ABL , , , , . · , , , , , . ABL · "2020 65 10 1 " " " .
. [= ] . (LUMC) . . . . , , . MRI . . 8 230 . MRI , . . 1 . 1 . . . . . . . Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the devel… [+196 chars]
. [= ] . (LUMC) . . . . , , . MRI . . 8 230 . MRI , . . 1 . 1 . . . . . . . Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the devel… [+196 chars]
[= ] . . ( ) · 26 . , , . . ‘’( ), ‘’( ) , . 527 (SYT11) . ‘SYT11’ . , . , ‘SYT11’ . “ ‘SYT11’ ” . “ , , ” “ SYT11 · ” . , , ‘Journal of Experimental & Clinical Cancer Research’(IF 1… [+7 chars]
